Uncategorized

Novo Nordisk A/S Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeks Amycretin demonstrated statistically significant reductions in HbA1c with

In brief The SEC has granted no-action relief stating it will not recommend enforcement if Fuse offers and sells its ENERGY token without registration,

Earlier this year, Amazon bought nearly 1 million shares of IonQ. Since Amazon took a stake in IonQ, the quantum computing stock has risen

NEED TO KNOW Susan, 62, lost 50+ lbs. ahead of her daughter’s wedding this year and decided to top it off with a facelift

The SEC has just issued its second “no-action letter” toward a decentralized physical infrastructure network (DePIN) crypto project in recent months, giving its native

Shubham Gupta, CFA, co-founder of Growthvine Capital, says, “SEBI’s $1 billion cap on overseas ETFs has already been fully utilised, meaning AMCs cannot currently

On November 12, 2025, SEC Chairman Atkins delivered remarks previewing how the Securities and Exchange Commission may seek to categorize digital assets as part

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in

“Our unwavering discipline drove our adjusted EBITDA to the top end of our guidance range, even as we navigated production delays in the U.S.,”

The use of Ozempic and similar weight loss drugs has become fairly common in celebrity circles. More and more stars are admitting slimming down